IDYA
IDYA
NASDAQ · Biotechnology

Ideaya Biosciences Inc

$31.23
-0.03 (-0.10%)
Financial Highlights (FY 2026)
Revenue
235.02M
Net Income
-122,172,328
Gross Margin
Profit Margin
-52.0%
Rev Growth
+62.5%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 60.1% 60.1%
Operating Margin -72.8% -65.6% -18.9% -18.0%
Profit Margin -52.0% -49.4% -21.1% -18.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 235.02M 144.59M 384.15M 440.58M
Gross Profit 230.71M 264.60M
Operating Income -171,186,382 -94,787,586 -72,666,854 -79,390,880
Net Income -122,172,328 -67,648,022 -80,984,777 -83,452,264
Gross Margin 60.1% 60.1%
Operating Margin -72.8% -65.6% -18.9% -18.0%
Profit Margin -52.0% -49.4% -21.1% -18.9%
Rev Growth +62.5% +62.5% -7.8% +21.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 452.34M 383.43M
Total Equity 2.04B 2.12B
D/E Ratio 0.22 0.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -168,287,651 -98,359,338 -85,173,040 -109,288,960
Free Cash Flow -100,075,430 -111,173,636